Correlation between Neutrophil-to-Lymphocyte Ratio and Severity of Community-Acquired Pneumonia in Patients
Abstract
The high morbidity and mortality rates due to pneumonia in developing countries indicate that a more affordable marker is needed to determine the degree of inflammation in cases of pneumonia infection. The neutrophil-to-lymphocyte ratio (NLR) is a simple indicator used extensively in evaluating the systemic inflammatory response. An observational cross-sectional study of 297 pneumonia patients was conducted using medical records as the source document. The patients’ blood was taken during the hospital admission to obtain neutrophil and lymphocyte values. Meanwhile, the PSI score was used during the hospital admission to assess the severity of the pneumonia. Bivariate analysis using Spearman correlation was used to determine the correlation between NLR and pneumonia severity. The ROC curve was used to determine the cut-off value of NLR to distinguish mild from severe patients. The results of the Spearman correlation test analysis showed that the correlation between the NLR and the pneumonia severity was significantly positive (r = 0.130; p = 0.025). Furthermore, the median NLR value was higher in patients with severe pneumonia than in those with milder pneumonia severity (13.01 vs. 11.79 vs. 6.75). The NLR cut-off value of 9.07 was obtained to differentiate patients with mild severity and those with more severe disease. In conclusion, there is a correlation between the neutrophil-to-lymphocyte ratio and the severity of patients’ pneumonia.
Full text article
References
Aston, S. J. (2017). Pneumonia in the developing world: Characteristic features and approach to management. Respirology, 22(7), 1276–1287. https://doi.org/10.1111/resp.13112
Biswas, M., et al. (2021). Association of sex, age, and comorbidities with mortality in COVID-19 patients: A systematic review and meta-analysis. Intervirology, 64, 36–47. https://doi.org/10.1159/000512592
Corica, B., et al. (2022). Sex and gender differences in community-acquired pneumonia. Internal and Emergency Medicine, 17(6), 1575–1588. https://doi.org/10.1007/s11739-022-02999-7
Curbelo, J., Luque, N., Rodriguez-Carballeira, M., Torres, A., & Agusti, C. (2017). Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio. PLOS ONE, 12(3), e0173947.
Diefenhardt, M., et al. (2019). Leukocytosis and neutrophilia as independent prognostic immunological biomarkers for clinical outcome in the CAO/ARO/AIO-04 randomized phase 3 rectal cancer trial. International Journal of Cancer, 145, 2282–2291.
Forget, P., Khalifa, C., Defour, J.-P., Latinne, D., Van Pel, M. C., & De Kock, M. (2017). What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Research Notes, 10(1), 12. https://doi.org/10.1186/s13104-016-2335-5
Gonzalez Quero, B., et al. (2017). Differences in community acquired pneumonia according to gender. European Respiratory Journal, 50(Suppl 61).
Grudzinska, F. S., et al. (2020). Neutrophils in community-acquired pneumonia: Parallels in dysfunction at the extremes of age. Thorax, 75(2), 164–171. https://doi.org/10.1136/thoraxjnl-2018-212826
Guthrie, G. J., Charles, K. A., Roxburgh, C. S., et al. (2013). The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer. Critical Reviews in Oncology/Hematology, 88, 218–230.
Huang, Y., Qin, Y., Liang, W., Huai, Y., Zhao, J., Su, W., et al. (2018). Diagnostic value of blood parameters for community-acquired pneumonia. International Immunopharmacology, 64, 10–15. https://doi.org/10.1016/j.intimp.2018.08.022
Kartal, O., & Kartal, A. T. (2017). Value of neutrophil to lymphocyte and platelet to lymphocyte ratios in pneumonia. Bratislava Medical Journal, 118(9), 513–516. https://doi.org/10.4149/BLL_2017_099
Kim, M., et al. (2019). Pneumonia severity index in viral community acquired pneumonia in adults. PLOS ONE, 14(3). https://doi.org/10.1371/journal.pone.0210102
Kuikel, S., et al. (2022). Neutrophil–lymphocyte ratio as a predictor of adverse outcome in patients with community-acquired pneumonia: A systematic review. Health Science Reports, 5(3). https://doi.org/10.1002/hsr2.630
Li, J., Chen, Q., Luo, X., Hong, J., Pan, K., Lin, X., et al. (2015). Neutrophil-to-lymphocyte ratio positively correlates to age in healthy population. Journal of Clinical Laboratory Analysis, 29(6), 437–443. https://doi.org/10.1002/jcla.21791
Lee, H., et al. (2021). Prognostic value of serial neutrophil-to-lymphocyte ratio measurements in hospitalized community-acquired pneumonia. PLOS ONE, 16(4), e0250067. https://doi.org/10.1371/journal.pone.0250067
Mujaković, A., Hadžiomerović, D., Pojskić, N., Krdžić, A., Ramas, A., & Sučić, M. (2022). Can neutrophil-to-lymphocyte ratio and proatherogenic risk factors improve the accuracy of pneumonia severity index in the prediction of community-acquired pneumonia outcome in healthy individuals? Medicinski Glasnik, 19(2). https://doi.org/10.17392/1464-22
Nirgude, D., Malge, M. H., Rajoli, S., & Rajanna, A. H. (2021). Study of absolute neutrophil absolute lymphocyte count ratio in community acquired pneumonia patients as a prognostic indicator at a tertiary care centre. Asian Journal of Medical Sciences, 12(9), 69–74. https://www.nepjol.info/index.php/AJMS/article/view/38008
Pantzaris, N. D., Platanaki, C., Pierrako, C., Karamouzos, V., & Velissaris, D. (2018). Neutrophil-to-lymphocyte ratio relation to sepsis severity scores and inflammatory biomarkers in patients with community-acquired pneumonia: A case series. Journal of Translational Internal Medicine, 6(1), 43–46. https://doi.org/10.2478/jtim-2018-0009
Peng, J., Qi, D., Yuan, G., Deng, X., Mei, Y., Feng, L., et al. (2020). Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study. Journal of Clinical Laboratory Analysis, 34(10), e23475. https://doi.org/10.1002/jcla.23475
Perhimpunan Dokter Paru Indonesia. (2020). Outbreak pneumonia di Tiongkok. https://infeksiemerging.kemkes.go.id/download/Press_Release_Outbreak_pneumonia_Pneumonia_Wuhan-17_Jan_2020.pdf
Perhimpunan Dokter Paru Indonesia. (2021). Panduan umum praktik klinis penyakit paru dan pernapasan. Jakarta: Perhimpunan Dokter Paru Indonesia.
Regunath, H., & Oba, Y. (2022). Community-acquired pneumonia. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK430749
Song, M., Lee, H., Kang, J. G., Kim, T.-Y., & Jeong, G. W. (2021). Neutrophil-to-lymphocyte ratio and mortality in the United States general population. Scientific Reports, 11, 464. https://doi.org/10.1038/s41598-020-79431-7
Ticona, J. H., et al. (2021). Community-acquired pneumonia: A focused review. American Journal of Medical Case Reports, 9(1), 45–52. https://doi.org/10.12691/ajmcr-9-1-12
Torres, A., et al. (2013). Risk factors for community-acquired pneumonia in adults in Europe: A literature review. Thorax, 68(11), 1057–1065.
Warny, M., et al. (2018). Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study. PLOS Medicine, 15(11), e1002685. https://doi.org/10.1371/journal.pmed.1002685
Wiersinga, W. J., Boersma, W. G., Jonkers, R. E., et al. (2018). Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). Netherlands Journal of Medicine, 76(1), 4–13.
Zahorec, R. (2021). Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratislava Medical Journal, 122(7), 474–488.
Zhou, H., Lan, T., & Guo, S. (2019). Stratified and prognostic value of admission lactate and severity scores in patients with community-acquired pneumonia in the emergency department: A single-center retrospective cohort study. Medicine, 98(41), e17479. https://doi.org/10.1097/MD.0000000000017479
Authors
Copyright (c) 2025 Naufalia Ghina Almira, Helmia Hasan, Puspa Wardhani, Yetti Hernaningsih, Siprianus Ugroseno Yudho Bintoro, Siprianus Ugroseno Yudho Bintoro, Pradana Zaky Romadhon
This work is licensed under a Creative Commons Attribution 4.0 International License.
Qanun Medika by FK UM Surabaya is liscence under Lisensi Creative Commons Atribusi 4.0 Internasional.